These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 11647564

  • 1. Monitoring of drug tests is faulted.
    Eichenwald K.
    N Y Times Web; 1998 Jun 12; ():A14. PubMed ID: 11647564
    [No Abstract] [Full Text] [Related]

  • 2. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM.
    Hum Res Rep; 1996 May 12; 11(5):1-3. PubMed ID: 11654438
    [No Abstract] [Full Text] [Related]

  • 3. Protection of human subjects.
    United States.
    Code Fed Regul Shipping; 1982 Oct 01; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Federal investigation concludes that institutional review boards are in trouble.
    Maloney DM.
    Hum Res Rep; 1998 Aug 01; 13(8):1-2. PubMed ID: 11657190
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Half-full or half-empty? Evaluating IRB performance.
    Mishkin B, Ariand N.
    Prof Ethics Rep; 1998 Aug 01; 11(3):4-7. PubMed ID: 11657925
    [No Abstract] [Full Text] [Related]

  • 9. Report says institutional review boards are conducting inadequate reviews.
    Maloney DM.
    Hum Res Rep; 1998 Sep 01; 13(9):1-2. PubMed ID: 11660603
    [No Abstract] [Full Text] [Related]

  • 10. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks.
    Puglisi JT, Ellis GB.
    Account Res; 1996 Sep 01; 4(3-4):261-5. PubMed ID: 11654521
    [No Abstract] [Full Text] [Related]

  • 11. All is not well in research on human subjects.
    Goldman J.
    N Y Times Web; 1986 Mar 06; ():A26. PubMed ID: 11647822
    [No Abstract] [Full Text] [Related]

  • 12. IRBs and epidemiologic research: how inappropriate restrictions hamper studies.
    Cann CI, Rothman KJ.
    IRB; 1984 Mar 06; 6(4):5-7. PubMed ID: 11649562
    [No Abstract] [Full Text] [Related]

  • 13. The noninstitutional review board: a case history.
    Herman SS.
    IRB; 1984 Mar 06; 6(1):1-3, 12. PubMed ID: 11649540
    [No Abstract] [Full Text] [Related]

  • 14. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J, Levine RJ.
    IRB; 1984 Mar 06; 6(4):8-10. PubMed ID: 11649563
    [No Abstract] [Full Text] [Related]

  • 15. IRBs and pharmaceutical company funding of research.
    Jellinek MS, Levine RJ.
    IRB; 1982 Oct 06; 4(8):9-10. PubMed ID: 11651693
    [No Abstract] [Full Text] [Related]

  • 16. Regulatory aspects of the distinction between research and medical practice.
    McCarthy CR.
    IRB; 1984 Oct 06; 6(3):7-8. PubMed ID: 11649567
    [No Abstract] [Full Text] [Related]

  • 17. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B.
    IRB; 1994 Oct 06; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract] [Full Text] [Related]

  • 18. IRBs under the microscope.
    Moreno JD.
    Kennedy Inst Ethics J; 1998 Sep 06; 8(3):329-37. PubMed ID: 11656936
    [No Abstract] [Full Text] [Related]

  • 19. U.S. halts research on humans at Duke: university can't ensure safety, probers find.
    Weiss R.
    Washington Post; 1999 May 12; ():A1, A20. PubMed ID: 11647726
    [No Abstract] [Full Text] [Related]

  • 20. Balancing moral principles in federal regulations on human research.
    Ackerman TF.
    IRB; 1992 May 12; 14(1):1-6. PubMed ID: 11652041
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.